Veritas Pharma (PK) Stock Price - VRTHF

0.15
0.0315 (26.58%)
0.15
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Veritas Pharma Inc (PK) VRTHF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0315 26.58% 0.15 0.1166 0.1585 0.1585 0.1185 16:30:02
Bid Price Ask Price Spread Spread % News
0.015 0.16 0.145 90.63% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
7 3,183 $ 0.13239 $ 421 2,927 0.047 - 0.367
Last Trade Time Type Quantity Stock Price Currency
14:07:57 100 $ 0.15 USD

Veritas Pharma (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.82M 12.16M - $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
12.00 $ - 0.00% - -

more financials information »

Veritas Pharma (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VRTHF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.11410.15850.100.11459811,6320.035931.46%
1 Month0.10960.15950.100.12293153,6960.040436.86%
3 Months0.0740.1720.0670.11507523,1300.076102.7%
6 Months0.131910.1720.0470.10486993,1320.0180913.71%
1 Year0.3670.3670.0470.16523013,001-0.217-59.13%
3 Years0.30780.8810.0470.412134354,785-0.1578-51.27%
5 Years0.3770.8810.0470.392673154,643-0.227-60.21%

Veritas Pharma (PK) Description

The medical marijuana industry is projected to have substantial growth over the next few years and Veritas is among the first to employ a comprehensive scientific approach behind medical marijuana claims. Our mission is to develop the most effective proprietary cannabis strains for specific disease conditions providing doctors and patients with conclusive scientific evidence for the recommendation and use of medical marijuana with confidence. Veritas has formed an exclusive partnership and investment in Cannevert Therapeutics, a high-level research and development company, with its main office on the University of British Columbia (UBC) campus. Cannevert has brought together a highly accredited team of pharmacologists, anaesthetists and chemists with proven track records of success in drug development in both academia and industry. This alliance will provide Veritas with the required technical ability to achieve its goals in research, development and commercialization.


Your Recent History
USOTC
VRTHF
Veritas Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.